感染性主动脉瘤腔内修复与开放手术修复的当代结局:一项系统综述
该系统综述纳入1998年1月至2023年1月间48篇文章、共1358例患者(75.8%男性,平均年龄66.9岁,1372个动脉瘤),比较腔内修复与开放手术修复感染性主动脉瘤的早期和晚期结局。腔内修复的早期死亡率低于开放手术(6.5% vs 15.9%),但晚期脓毒症发生率(5.7% vs 0.9%)和再干预率(17.6% vs 7.3%)更高,1年和5年汇总生存率两组相似。
要点
- 腔内修复治疗肾上型和肾下型感染性主动脉瘤的早期死亡率低于开放手术。
- 腔内修复后晚期脓毒症发生率和再干预率高于开放手术。
- 两组1年和5年汇总生存率相似。
核心结论
- 当前文献提示腔内修复是治疗胸降主动脉、肾上型和肾下型感染性主动脉瘤的有效且安全的开放手术替代方案。
- 但腔内修复与随访期间更高的感染相关并发症和再干预风险相关。
研究设计与样本
- 系统综述,检索1998年1月至2023年1月间关于腔内修复或开放手术修复治疗感染性主动脉瘤的文献。
- 纳入48篇文章,共1358例患者(75.8%男性;平均年龄66.9岁;1372个动脉瘤),开放修复占49.8%,腔内修复占50.2%。
- 分析患者人口学特征、早期和晚期结局,并按治疗方式和感染性主动脉瘤位置进行比较。
主要发现
- 亚洲和欧洲国家最常见的病原体分别为沙门菌属和葡萄球菌属。
- 胸降主动脉感染性主动脉瘤接受腔内修复的数量增加(27.9% vs 12.8%)。
- 肾上型感染性主动脉瘤腔内修复的早期死亡率为5.4% vs 开放手术43.2%;肾下型为1.8% vs 16.7%。
- 总体腔内修复的术中死亡率(1.0% vs 1.8%)和早期死亡率(6.5% vs 15.9%)低于开放手术。
- 腔内修复的晚期脓毒症发生率(5.7% vs 0.9%)和再干预率(17.6% vs 7.3%)高于开放手术;两组1年和5年汇总生存率相似。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To perform a systematic review on contemporary outcomes of endovascular repair and open surgical repair (OSR) for the treatment of mycotic aortic aneurysm (MAA). METHODS: A comprehensive literature search on the management of MAAs with endovascular repair or OSR was performed between January 1998 and January 2023. Patient demographics, early and late outcomes were analyzed with respect to treatment modality and MAA location. RESULTS: Forty-eight articles were included, encompassing a total of 1,358 patients (75.8% male; mean age 66.9 years; 1,372 aneurysms) treated by open (49.8%) or endovascular (50.2%) repair. Salmonella spp., and Staphylococcus spp. were the most prevalent pathogens in Asian and European countries respectively. An increasing number of descending thoracic MAAs were managed by endovascular repair (27.9% vs. 12.8%). Early mortality rates for supra- and infra-renal MAAs managed by endovascular repair were lower than OSR (suprarenal 5.4% vs. 43.2%; infrarenal 1.8% vs. 16.7%). Overall, endovascular repair demonstrated lower intraoperative (1.0% vs. 1.8%) and early mortality (6.5% vs. 15.9) rates than OSR. However, endovascular repair was associated with higher late sepsis rate (5.7% vs. 0.9%) and reintervention rate (17.6% vs. 7.3%). Pooled survival rates at 1- and 5-year were similar between the 2 groups. CONCLUSIONS: Current literature suggest that endovascular repair is an effective and safe alternative to OSR for descending thoracic, suprarenal, and infrarenal MAAs. However, endovascular repair is associated with higher risk of infection-related complications and reintervention during follow-up.
引用
- Li HL, Kwan KJS, Chan YC, et al. Contemporary Outcomes of Endovascular and Open Surgical Repair for Mycotic Aortic Aneurysms: A Systematic Review. Ann Vasc Surg. 2023. PMID: 37898457. doi:10.1016/j.avsg.2023.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。